Laddar...
Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease
BACKGROUND: The efficacy of adalimumab in inducing and maintaining remission in children with moderately to severely active Crohn's disease was shown in the IMAgINE 1 trial (NCT00409682). As per protocol, nonresponders or patients experiencing flare(s) on every other week (EOW) maintenance dosi...
Sparad:
| I publikationen: | Inflamm Bowel Dis |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Lippincott Williams & Wilkins
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4794130/ https://ncbi.nlm.nih.gov/pubmed/26950307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000000715 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|